Related Experiment Video
Updated: Jul 22, 2026

Protocol for Isolation of Primary Human Hepatocytes and Corresponding Major Populations of Non-parenchymal Liver Cells
Published on: March 30, 2016
[Isolated hepatocytes and their potential therapeutic use]
A C Puviani1, C Ottolenghi, P Pazzi
1Dipartimento di Biologia, Università di Ferrara.
This review explores how hepatocytes are isolated and their potential use in treating liver diseases. The study looks at different methods for isolating liver cells and evaluating their quality. It also discusses recent clinical trials using these cells for liver support. The authors suggest that isolated hepatocytes may help patients with liver damage or inherited conditions. The focus is on improving isolation techniques and assessing cell function.
Area of Science:
- Cell culture techniques within hepatology
- Translational research in liver disease
- Pharmacological screening methods
Background:
Liver cell research remains limited by the lack of reliable models for studying hepatic function. Prior research has shown that cultured cells often fail to maintain metabolic activity. This gap motivated the search for better isolation methods. Traditional models do not fully replicate in vivo conditions. Hepatocytes are central to drug metabolism studies. However, few systems preserve their functional integrity. Researchers have explored various isolation protocols. Yet, standardization of these methods remains unresolved.
Purpose Of The Study:
This review aims to clarify current hepatocyte isolation techniques and their clinical relevance. The specific problem is the variability in isolation outcomes across species. The motivation stems from the need for reliable cell sources for research and therapy. Hepatocytes must retain viability and function post-isolation. The study focuses on enzymatic methods and functional assessment. It also addresses recent clinical applications of isolated cells. The goal is to provide a framework for evaluating isolation success. This work supports both basic research and translational applications.
Main Methods:
The authors examined enzymatic digestion protocols for liver cell isolation. They analyzed methods for assessing cell viability and purity. Techniques for evaluating cell morphology were also reviewed. The study compared different species-specific protocols. Functional assays included metabolic activity measurements. The focus was on reproducibility and standardization. No single method was declared superior. The review considered both qualitative and quantitative metrics.
Main Results:
Enzymatic digestion remains the primary method for hepatocyte isolation. Collagenase is widely used for its effectiveness in mammalian species. Cell viability is typically measured using trypan blue exclusion. Purity is assessed through flow cytometry and marker expression. Morphological evaluation includes light and electron microscopy. Functional tests involve albumin production and drug metabolism. Allogeneic and xenogeneic transplants showed early promise. These results suggest potential for liver support systems.
Conclusions:
The authors propose that improved isolation methods could enhance clinical applications. They suggest that standardized protocols are essential for reliable outcomes. The review highlights the importance of functional testing. No prior work had resolved the issue of functional decline in culture. The findings support the use of isolated hepatocytes in liver support systems. The authors suggest that these cells may serve as temporary substitutes. They propose that further refinement of isolation methods is needed. These conclusions align with the study's focus on clinical translation.
Frequently Asked Questions
Isolated hepatocytes are used to study liver metabolism and drug effects. They help evaluate xenobiotic impacts on liver function.
Collagenase is frequently used to isolate hepatocytes from mammalian species.
Viability ensures cells can be used in experiments or transplants. Low viability reduces functional relevance.
They serve as temporary liver substitutes for patients with acute or chronic liver failure.
Purity is measured using flow cytometry and specific marker expression.
The authors suggest they may be used to treat inherited metabolic liver diseases.

